Kubota Vision, the American subsidiary of the Japanese-based Kubota Pharmaceutical Holdings, last month enrolled its first patient for a clinical study aimed at controlling the development of myopia. Two months ago, the company reported positive results on a first research where myopically defocused images were projected by electronic tabletop devices ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.